SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-008069
Filing Date
2019-08-13
Accepted
2019-08-13 16:29:18
Documents
67
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20190630x10q.htm 10-Q 2496261
2 EX-31.1 knsa-20190630ex311e09503.htm EX-31.1 12914
3 EX-31.2 knsa-20190630ex3123c4a35.htm EX-31.2 11757
4 EX-32.1 knsa-20190630ex321fefa09.htm EX-32.1 7081
5 EX-32.2 knsa-20190630ex32279e4c3.htm EX-32.2 6975
  Complete submission text file 0001558370-19-008069.txt   7406203

Data Files

Seq Description Document Type Size
6 EX-101.INS knsa-20190630.xml EX-101.INS 1209787
7 EX-101.SCH knsa-20190630.xsd EX-101.SCH 54889
8 EX-101.CAL knsa-20190630_cal.xml EX-101.CAL 45683
9 EX-101.DEF knsa-20190630_def.xml EX-101.DEF 266015
10 EX-101.LAB knsa-20190630_lab.xml EX-101.LAB 480075
11 EX-101.PRE knsa-20190630_pre.xml EX-101.PRE 394627
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 191021042
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1